RNA science is now translated into new therapies…
Seven RNA-based products are now approved
More than one hundred candidates have reached the clinical stage…
“BRIEFING ON RNA TRIALS” provides you an accurate overview
to explore the latest trials in this dynamic and rapidly evolving field
FOUR REASONS TO BUY:
Wishing to identify hot research topics in this highly competitive field ?
Looking for an update on the clinical portfolio ?
Needing insights to assist you in your decision-making in RNA drug
or to identify the most advanced companies in the field ?
Searching for new candidates to in-license ?
« BRIEFING ON RNA TRIALS » is the up-dated tool you need to have
- 220 pages detailing more than 160 clinical trials conducted in 45 countries
- 48 companies and academic institutions developing more than RNA therapeutics (antisense oligonucleotides, RNAi/siRNA, microRNA, mRNA…)
- 58 targets and 62 diseases in a wide range of therapeutic areas
(cancers, cardiovascular and metabolic diseases, infectious diseases,
genetic diseases, ophthalmological diseases….).
Each Technical Datasheet includes for every trial: Identification number, Sponsor, Product, Status, Start/Planned Completion, Estimated Enrollment, Collaborations, Number of sites, Updated, Contact, Latest Related Informations/Publications.